FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Argatroban Injection
Status: Discontinuation
»Therapeutic Categories: Hematology

Novartis (New 01/15/2020)

Company Contact Information:

Presentation Posting Date Related Information
250 mg/2.5 mL (100 mg/mL), single dose vial (NDC 0078-0930-61) 01/15/2020 Novartis Pharmaceuticals has made a business decision to permanently discontinue the product Argatroban Injection, Vial 250 mg/2.5 mL.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English